Global Microgravity Biopharmaceuticals Market Growth (Status and Outlook) 2026-2032

January 2026 | 92 pages | ID: G0AC2DE8DF27EN
LP Information

Abstracts

The global Microgravity Biopharmaceuticals market size is predicted to grow from US$ 63.97 million in 2025 to US$ 129 million in 2032; it is expected to grow at a CAGR of 10.6% from 2026 to 2032.

Microgravity biopharmaceuticals is an interdisciplinary field that utilizes the microgravity environment provided by space stations, sounding rockets, and other similar facilities to conduct research on key aspects of drug development and production. Its core lies in the fact that microgravity can significantly suppress gravity-driven convection and sedimentation effects, thereby creating homogenization conditions that cannot be simulated on Earth. This is primarily used for high-quality protein crystallization and the development of novel drug formulations and efficient production processes. This technology aims to overcome bottlenecks in terrestrial research and development and is one of the most commercially promising directions for space-based biomanufacturing.

The microgravity biopharmaceuticals market is at a critical juncture, transitioning from exploratory research to early-stage commercialization. Currently, the market is primarily driven by collaborations between government space agencies and large pharmaceutical companies, focusing on two high-value areas: high-quality protein crystallization and advanced disease model development. As commercial space companies offer more economical launch and platform services, the barriers to entry continue to decrease, attracting a number of biotech startups focused on specific therapeutic areas such as cancer and neurodegenerative diseases. However, the overall market size remains limited, with the vast majority of projects still in the research and validation phase. Future development heavily relies on comparative experiments to definitively demonstrate that microgravity environments can systematically produce commercially viable research results or products superior to those on Earth, ensuring continued industry investment.

This report presents a comprehensive overview, market shares, and growth opportunities of Microgravity Biopharmaceuticals market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Protein Crystal Growth
• Microbial Fermentation
• Advanced Disease Model Construction
• Others

Segmentation by Stage:

• Drug Discovery
• Preclinical Research
• Process Development
• On-Orbit Production
• Others

Segmentation by Application:

• New Drug Discovery
• Preclinical Research and Translational Medicine
• Others

This report also splits the market by region:

• United States
• China%li%
• Europe
• Other regions
• Japan
• South Korea
• Southeast Asia
• Rest of world

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

• BioOrbit
• Eascra Biotech
• Exobiosphere
• Space LiinTech
• SpacePharma
• Varda Space Industries
• Voyager Technologies

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Microgravity Biopharmaceuticals Market Size 2026-2032
  2.1.2 Microgravity Biopharmaceuticals Market Size CAGR by Region
2.2 Microgravity Biopharmaceuticals Segment by Type
  2.2.1 Protein Crystal Growth
  2.2.2 Microbial Fermentation
  2.2.3 Advanced Disease Model Construction
  2.2.4 Others
  2.2.5 Microgravity Biopharmaceuticals Market Size by Type
    2.2.5.1 Global Microgravity Biopharmaceuticals Market Size Market Share by Type (2026-2032)
    2.2.5.2 Global Microgravity Biopharmaceuticals Market Size Growth Rate by Type (2026-2032)
2.3 Microgravity Biopharmaceuticals Segment by Stage
  2.3.1 Drug Discovery
  2.3.2 Preclinical Research
  2.3.3 Process Development
  2.3.4 On-Orbit Production
  2.3.5 Others
  2.3.6 Microgravity Biopharmaceuticals Market Size by Stage
    2.3.6.1 Global Microgravity Biopharmaceuticals Market Size Market Share by Stage (2026-2032)
    2.3.6.2 Global Microgravity Biopharmaceuticals Market Size Growth Rate by Stage (2026-2032)
2.4 Microgravity Biopharmaceuticals Segment by Application
  2.4.1 New Drug Discovery
  2.4.2 Preclinical Research and Translational Medicine
  2.4.3 Others
  2.4.4 Microgravity Biopharmaceuticals Market Size by Application (2026-2032)
    2.4.4.1 Global Microgravity Biopharmaceuticals Market Size Market Share by Application (2026-2032)
    2.4.4.2 Global Microgravity Biopharmaceuticals Market Size Growth Rate by Application (2026-2032)

3 MICROGRAVITY BIOPHARMACEUTICALS KEY PLAYERS

3.1 Date of Key Players Enter into Microgravity Biopharmaceuticals
3.2 Key Players Microgravity Biopharmaceuticals Product Offered
3.3 Key Players Microgravity Biopharmaceuticals Funding/Investment Analysis
3.4 Funding/Investment
  3.4.1 Funding/Investment by Regions
  3.4.2 Funding/Investment by End-Industry
3.5 Key Players Microgravity Biopharmaceuticals Valuation & Market Capitalization
3.6 Key Players Mergers & Acquisitions, Expansion Plans
3.7 Market Ranking
3.8 New Product/Technology Launches
3.9 Partnerships, Agreements, and Collaborations
3.10 Mergers and Acquisitions

4 MICROGRAVITY BIOPHARMACEUTICALS BY REGIONS

4.1 Microgravity Biopharmaceuticals Market Size by Regions (2026-2032)
4.2 United States Microgravity Biopharmaceuticals Market Size Growth (2026-2032)
4.3 China Microgravity Biopharmaceuticals Market Size Growth (2026-2032)
4.4 Europe Microgravity Biopharmaceuticals Market Size Growth (2026-2032)
4.5 Rest of World Microgravity Biopharmaceuticals Market Size Growth (2026-2032)

5 UNITED STATES

5.1 United States Microgravity Biopharmaceuticals Market Size by Type (2026-2032)
5.2 United States Microgravity Biopharmaceuticals Market Size by Application (2026-2032)

6 EUROPE

6.1 Europe Microgravity Biopharmaceuticals Market Size by Type (2026-2032)
6.2 Europe Microgravity Biopharmaceuticals Market Size by Application (2026-2032)

7 CHINA

7.1 China Microgravity Biopharmaceuticals Market Size by Type (2026-2032)
7.2 China Microgravity Biopharmaceuticals Market Size by Application (2026-2032)

8 REST OF WORLD

8.1 Rest of World Microgravity Biopharmaceuticals Market Size by Type (2026-2032)
8.2 Rest of World Microgravity Biopharmaceuticals Market Size by Application (2026-2032)
8.3 Japan
8.4 South Korea
8.5 Southeast Asia

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 KEY INVESTORS IN MICROGRAVITY BIOPHARMACEUTICALS

10.1 Company A
  10.1.1 Company A Company Details
  10.1.2 Company Description
  10.1.3 Companies Invested by Company A
  10.1.4 Company A Key Development and Market Layout
10.2 Company B
  10.2.1 Company B Company Details
  10.2.2 Company Description
  10.2.3 Companies Invested by Company B
  10.2.4 Company B Key Development and Market Layout
10.3 Company C
  10.3.1 Company C Company Details
  10.3.2 Company Description
  10.3.3 Companies Invested by Company C
  10.3.4 Company C Key Development and Market Layout
10.4 Company D
10.5 ……

11 KEY PLAYERS ANALYSIS

11.1 BioOrbit
  11.1.1 BioOrbit Company Details
  11.1.2 BioOrbit Microgravity Biopharmaceuticals Product Offered
  11.1.3 BioOrbit Microgravity Biopharmaceuticals Market Size (2025 VS 2031)
  11.1.4 BioOrbit Main Business Overview
  11.1.5 BioOrbit News
11.2 Eascra Biotech
  11.2.1 Eascra Biotech Company Details
  11.2.2 Eascra Biotech Microgravity Biopharmaceuticals Product Offered
  11.2.3 Eascra Biotech Microgravity Biopharmaceuticals Market Size (2025 VS 2031)
  11.2.4 Eascra Biotech Main Business Overview
  11.2.5 Eascra Biotech News
11.3 Exobiosphere
  11.3.1 Exobiosphere Company Details
  11.3.2 Exobiosphere Microgravity Biopharmaceuticals Product Offered
  11.3.3 Exobiosphere Microgravity Biopharmaceuticals Market Size (2025 VS 2031)
  11.3.4 Exobiosphere Main Business Overview
  11.3.5 Exobiosphere News
11.4 Space LiinTech
  11.4.1 Space LiinTech Company Details
  11.4.2 Space LiinTech Microgravity Biopharmaceuticals Product Offered
  11.4.3 Space LiinTech Microgravity Biopharmaceuticals Market Size (2025 VS 2031)
  11.4.4 Space LiinTech Main Business Overview
  11.4.5 Space LiinTech News
11.5 SpacePharma
  11.5.1 SpacePharma Company Details
  11.5.2 SpacePharma Microgravity Biopharmaceuticals Product Offered
  11.5.3 SpacePharma Microgravity Biopharmaceuticals Market Size (2025 VS 2031)
  11.5.4 SpacePharma Main Business Overview
  11.5.5 SpacePharma News
11.6 Varda Space Industries
  11.6.1 Varda Space Industries Company Details
  11.6.2 Varda Space Industries Microgravity Biopharmaceuticals Product Offered
  11.6.3 Varda Space Industries Microgravity Biopharmaceuticals Market Size (2025 VS 2031)
  11.6.4 Varda Space Industries Main Business Overview
  11.6.5 Varda Space Industries News
11.7 Voyager Technologies
  11.7.1 Voyager Technologies Company Details
  11.7.2 Voyager Technologies Microgravity Biopharmaceuticals Product Offered
  11.7.3 Voyager Technologies Microgravity Biopharmaceuticals Market Size (2025 VS 2031)
  11.7.4 Voyager Technologies Main Business Overview
  11.7.5 Voyager Technologies News

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Microgravity Biopharmaceuticals Market Size CAGR by Region (2026-2032) ($ millions)
Table 2. Major Players of Protein Crystal Growth
Table 3. Major Players of Microbial Fermentation
Table 4. Major Players of Advanced Disease Model Construction
Table 5. Major Players of Others
Table 6. Global Market Size by Type (2026-2032) ($ millions)
Table 7. Global Microgravity Biopharmaceuticals Market Size Market Share by Type (2026-2032)
Table 8. Major Players of Drug Discovery
Table 9. Major Players of Preclinical Research
Table 10. Major Players of Process Development
Table 11. Major Players of On-Orbit Production
Table 12. Major Players of Others
Table 13. Global Market Size by Stage (2026-2032) ($ millions)
Table 14. Global Microgravity Biopharmaceuticals Market Size Market Share by Stage (2026-2032)
Table 15. Global Microgravity Biopharmaceuticals Market Size by Application (2026-2032) ($ millions)
Table 16. Global Microgravity Biopharmaceuticals Market Size Market Share by Application (2026-2032)
Table 17. Date of Global Key Players Enter into Microgravity Biopharmaceuticals Market
Table 18. Global Key Players Microgravity Biopharmaceuticals Product Offered
Table 19. Key Players Microgravity Biopharmaceuticals Funding/Investment (Million USD)
Table 20. Funding/Investment by Regions
Table 21. Funding/Investment by End-Industry
Table 22. Key Players Microgravity Biopharmaceuticals Valuation & Market Capitalization (Million USD)
Table 23. Key Players Mergers & Acquisitions, Expansion Plans
Table 24. Microgravity Biopharmaceuticals New Product/Technology Launches
Table 25. Microgravity Biopharmaceuticals Industry Partnerships, Agreements, and Collaborations
Table 26. Microgravity Biopharmaceuticals Industry Mergers and Acquisitions
Table 27. Global Microgravity Biopharmaceuticals Market Size by Regions 2026-2032 ($ millions)
Table 28. Global Microgravity Biopharmaceuticals Market Size Market Share by Regions 2026-2032
Table 29. United States Microgravity Biopharmaceuticals Market Size by Type (2026-2032) ($ millions)
Table 30. United States Microgravity Biopharmaceuticals Market Size Market Share by Type (2026-2032)
Table 31. United States Microgravity Biopharmaceuticals Market Size by Application (2026-2032) ($ millions)
Table 32. United States Microgravity Biopharmaceuticals Market Size Market Share by Application (2026-2032)
Table 33. Europe Microgravity Biopharmaceuticals Market Size by Type (2026-2032) ($ millions)
Table 34. Europe Microgravity Biopharmaceuticals Market Size Market Share by Type (2026-2032)
Table 35. Europe Microgravity Biopharmaceuticals Market Size by Application (2026-2032) ($ millions)
Table 36. Europe Microgravity Biopharmaceuticals Market Size Market Share by Application (2026-2032)
Table 37. China Microgravity Biopharmaceuticals Market Size by Type (2026-2032) ($ millions)
Table 38. China Microgravity Biopharmaceuticals Market Size Market Share by Type (2026-2032)
Table 39. China Microgravity Biopharmaceuticals Market Size by Application (2026-2032) ($ millions)
Table 40. China Microgravity Biopharmaceuticals Market Size Market Share by Application (2026-2032)
Table 41. Rest of World Microgravity Biopharmaceuticals Market Size by Type (2026-2032) ($ millions)
Table 42. Rest of World Microgravity Biopharmaceuticals Market Size Market Share by Type (2026-2032)
Table 43. Rest of World Microgravity Biopharmaceuticals Market Size by Application (2026-2032) ($ millions)
Table 44. Rest of World Microgravity Biopharmaceuticals Market Size Market Share by Application (2026-2032)
Table 45. Key Market Drivers & Growth Opportunities of Microgravity Biopharmaceuticals
Table 46. Key Market Challenges & Risks of Microgravity Biopharmaceuticals
Table 47. Key Industry Trends of Microgravity Biopharmaceuticals
Table 48. Company A Company Details
Table 49. Companies Invested by Company A
Table 50. Company A Key Development and Market Layout
Table 51. Company B Company Details
Table 52. Companies Invested by Company B
Table 53. Company B Key Development and Market Layout
Table 54. Company C Company Details
Table 55. Companies Invested by Company C
Table 56. Company C Key Development and Market Layout
Table 57. BioOrbit Basic Information, Head Office, Major Market Areas and Its Competitors
Table 58. BioOrbit Microgravity Biopharmaceuticals Market Size (2025 VS 2031)
Table 59. Eascra Biotech Basic Information, Head Office, Major Market Areas and Its Competitors
Table 60. Eascra Biotech Microgravity Biopharmaceuticals Market Size (2025 VS 2031)
Table 61. Exobiosphere Basic Information, Head Office, Major Market Areas and Its Competitors
Table 62. Exobiosphere Microgravity Biopharmaceuticals Market Size (2025 VS 2031)
Table 63. Space LiinTech Basic Information, Head Office, Major Market Areas and Its Competitors
Table 64. Space LiinTech Microgravity Biopharmaceuticals Market Size (2025 VS 2031)
Table 65. SpacePharma Basic Information, Head Office, Major Market Areas and Its Competitors
Table 66. SpacePharma Microgravity Biopharmaceuticals Market Size (2025 VS 2031)
Table 67. Varda Space Industries Basic Information, Head Office, Major Market Areas and Its Competitors
Table 68. Varda Space Industries Microgravity Biopharmaceuticals Market Size (2025 VS 2031)
Table 69. Voyager Technologies Basic Information, Head Office, Major Market Areas and Its Competitors
Table 70. Voyager Technologies Microgravity Biopharmaceuticals Market Size (2025 VS 2031)

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Microgravity Biopharmaceuticals
Figure 2. Microgravity Biopharmaceuticals Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Microgravity Biopharmaceuticals Market Size Growth Rate 2026-2032 ($ millions)
Figure 7. Microgravity Biopharmaceuticals Market Size by Region (2025 & 2032) ($ millions)
Figure 8. Global Microgravity Biopharmaceuticals Market Size Market Share by Type (2026-2032)
Figure 9. Global Protein Crystal Growth Market Size Growth Rate
Figure 10. Global Microbial Fermentation Market Size Growth Rate
Figure 11. Global Microgravity Biopharmaceuticals Market Size Market Share by Stage (2026-2032)
Figure 12. Global Drug Discovery Market Size Growth Rate
Figure 13. Global Preclinical Research Market Size Growth Rate
Figure 14. Microgravity Biopharmaceuticals in New Drug Discovery
Figure 15. Global Microgravity Biopharmaceuticals Market: New Drug Discovery (2026-2032) ($ millions)
Figure 16. Microgravity Biopharmaceuticals in Preclinical Research and Translational Medicine
Figure 17. Global Microgravity Biopharmaceuticals Market: Preclinical Research and Translational Medicine (2026-2032) ($ millions)
Figure 18. Microgravity Biopharmaceuticals in Others
Figure 19. Global Microgravity Biopharmaceuticals Market: Others (2026-2032) ($ millions)
Figure 20. Global Microgravity Biopharmaceuticals Market Size Market Share by Application (2026-2032)
Figure 21. Global Microgravity Biopharmaceuticals Market Size in New Drug Discovery Growth Rate
Figure 22. Global Microgravity Biopharmaceuticals Market Size in Preclinical Research and Translational Medicine Growth Rate
Figure 23. Funding/Investment
Figure 24. Global Microgravity Biopharmaceuticals Market Size Market Share by Regions 2026-2032
Figure 25. United States Microgravity Biopharmaceuticals Market Size 2026-2032 ($ millions)
Figure 26. China Microgravity Biopharmaceuticals Market Size 2026-2032 ($ millions)
Figure 27. Europe Microgravity Biopharmaceuticals Market Size 2026-2032 ($ millions)
Figure 28. Rest of World Microgravity Biopharmaceuticals Market Size 2026-2032 ($ millions)
Figure 29. United States Microgravity Biopharmaceuticals Consumption Market Share by Type in 2030
Figure 30. United States Microgravity Biopharmaceuticals Market Size Market Share by Application in 2030
Figure 31. Europe Microgravity Biopharmaceuticals Consumption Market Share by Type in 2030
Figure 32. Europe Microgravity Biopharmaceuticals Market Size Market Share by Application in 2030
Figure 33. China Microgravity Biopharmaceuticals Consumption Market Share by Type in 2030
Figure 34. China Microgravity Biopharmaceuticals Market Size Market Share by Application in 2030
Figure 35. Rest of World Microgravity Biopharmaceuticals Consumption Market Share by Type in 2030
Figure 36. Rest of World Microgravity Biopharmaceuticals Market Size Market Share by Application in 2030